Core Viewpoint - The company, Aihuilong (688575.SH), has received a medical device registration certificate from the National Medical Products Administration for its product, which is a kit for the quantitative determination of human chorionic gonadotropin and its beta subunit in serum or plasma [1] Group 1 - The product is intended for in vitro quantitative measurement of human chorionic gonadotropin and its beta subunit levels in human serum and/or plasma [1] - It is primarily used for dynamic monitoring of malignant tumor patients to assist in assessing disease progression or treatment effectiveness [1] - The product is not intended for early diagnosis or confirmation of malignant tumors and is not used for tumor screening in the general population [1]

Core Viewpoint - The company, Aihuilong (688575.SH), has received a medical device registration certificate from the National Medical Products Administration for its product, which is a kit for the quantitative determination of human chorionic gonadotropin and its beta subunit in human serum and/or plasma [1] Group 1 - The product is primarily used for dynamic monitoring of malignant tumor patients to assist in assessing disease progression or treatment effectiveness [1] - The kit is not intended for early diagnosis or confirmation of malignant tumors and is not used for tumor screening in the general population [1]